219 related articles for article (PubMed ID: 14585889)
1. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound.
Bath LE; Wallace WH; Shaw MP; Fitzpatrick C; Anderson RA
Hum Reprod; 2003 Nov; 18(11):2368-74. PubMed ID: 14585889
[TBL] [Abstract][Full Text] [Related]
2. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
[TBL] [Abstract][Full Text] [Related]
3. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
4. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
5. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
[TBL] [Abstract][Full Text] [Related]
6. Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l.
Larsen EC; Müller J; Rechnitzer C; Schmiegelow K; Andersen AN
Hum Reprod; 2003 Feb; 18(2):417-22. PubMed ID: 12571182
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.
Fanchin R; Schonäuer LM; Righini C; Guibourdenche J; Frydman R; Taieb J
Hum Reprod; 2003 Feb; 18(2):323-7. PubMed ID: 12571168
[TBL] [Abstract][Full Text] [Related]
8. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
9. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
[TBL] [Abstract][Full Text] [Related]
10. The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea.
Jonard S; Pigny P; Jacquesson L; Demerle-Roux C; Robert Y; Dewailly D
Hum Reprod; 2005 Jan; 20(1):101-7. PubMed ID: 15513979
[TBL] [Abstract][Full Text] [Related]
11. Impact of cancer therapies on ovarian reserve.
Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.
Pigny P; Merlen E; Robert Y; Cortet-Rudelli C; Decanter C; Jonard S; Dewailly D
J Clin Endocrinol Metab; 2003 Dec; 88(12):5957-62. PubMed ID: 14671196
[TBL] [Abstract][Full Text] [Related]
13. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
[TBL] [Abstract][Full Text] [Related]
14. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
15. Intracycle variation in number of antral follicles stratified by size and in endocrine markers of ovarian reserve in women with normal ovulatory menstrual cycles.
Deb S; Campbell BK; Clewes JS; Pincott-Allen C; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2013 Feb; 41(2):216-22. PubMed ID: 22744915
[TBL] [Abstract][Full Text] [Related]
16. [Ovarian function in young women after anticancer treatment in childhood].
Krawczuk-Rybak M; Leszczyńska E; Zelazowska-Rutkowska B; Wysocka J
Med Wieku Rozwoj; 2008; 12(4 Pt 2):1028-34. PubMed ID: 19531821
[TBL] [Abstract][Full Text] [Related]
17. Reduction of ovarian reserve in adult patients with dermatomyositis.
de Souza FH; Shinjo SK; Yamakami LY; Viana VS; Baracat EC; Bonfá E; Silva CA
Clin Exp Rheumatol; 2015; 33(1):44-9. PubMed ID: 25571898
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of some ovarian reserve tests in poor responders.
Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
[TBL] [Abstract][Full Text] [Related]
19. Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy.
Aikawa NE; Sallum AM; Pereira RM; Suzuki L; Viana VS; Bonfá E; Silva CA
Clin Exp Rheumatol; 2012; 30(3):445-9. PubMed ID: 22703605
[TBL] [Abstract][Full Text] [Related]
20. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E
Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
